● Recruiting

Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs)

Condition: Cancer · Sponsor: Institut Curie

PhaseNA

Planned participants50

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The IMMUNO-TET trial aims to assess the feasibility of characterising the immune environment of TETs and the constitutional and somatic molecular profiles of patients with localised thymic epithelial tumour (TET).

This description comes directly from the study's public registry record.

Talk to the study team

Nicolas GIRARD, MD · 0156245539 · nicolas.girard2@curie.fr

Always discuss trial participation with your own doctor first.

Locations (3)

Institut Curie Paris	Paris, France	Recruiting
Institut Mutualiste Montsouris	Paris, France	Recruiting
Hôpital FOCH	Suresnes, France	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05558644